Icon

INBRIJA (nda209184)- (42MG)

LEVODOPA ACORDA
42MG
No Yes
2032-Nov-16 Expired
None 2021-Dec-21
None No
INBRIJA is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson’s disease treated with carbidopa/levodopa.
0 0 0
Total Other Developers None
Drugs with Suitability No
42MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.